Vaginal microbiome-drug interactions affect antibiotic treatment for bacterial vaginosis, emphasizing the need for ...

Bacterial Vaginosis Market Epidemiology Report 2025-2035: Drug Pipeline, Treatment, Trends, Rising Incidence & prevalence The report also provides a detailed analysis of the current bacterial ...

High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. Sex Transm Dis. 2019 May;46 (5):304-311. doi: 10.1097/OLQ.0000000000000972. PMID: 30624309.

Women's vaginal discharge is not normal if it has an unpleasant odor, itching, or pain during sexual intercourse and ...

Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM) today announced that a study of SOLOSEC® (secnidazole) 2 g oral granules for recurrent bacterial vaginosis (BV) presented at the ...

Bacterial Vaginosis: An Update on Diagnosis and Treatment Hans Verstraelen; Rita Verhelst Disclosures Expert Rev Anti Infect Ther. 2009;7 (9):1109-1124. 0 ...

Bacterial vaginosis is further associated with a sizeable burden of infectious complications. Diagnosis relies on standardized clinical criteria or on scoring bacterial cell morphotypes on a Gram ...

Precisio Biotix Therapeutics, Inc. (Precisio) Announces a Grant for the Discovery of Novel Engineered Lysin Antimicrobials Targeting Bacterial Vaginosis Associated Pathobionts (BV) ...

Valentina Milanova, founder of Daye, believes that for years, we’ve been using outdated and ill-matched technology to test for viruses and pathogens that cause women’s health issues. Daye’s diagnostic ...

Precisio will use its proprietary AI/ML-guided Zeus ™-LysiThru™ platform technologies to discover engineered lysins with superior activity and specificity with funding support from the Gates ...